Inventor
WEGMANN FRANK
NL8 patents
⚠️ This page may combine multiple inventors who share the name “WEGMANN FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN VACCINES & PREVENTION BV
6 patentsUS10369214B2Aug 6, 2019
Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
JANSSEN VACCINES & PREVENTION BV5 citations80
US11896663B2Feb 13, 2024
Immunodeficiency virus type 1 (HIV-1) mutant envelope proteins
JANSSEN VACCINES & PREVENTION BV0 citations59
US10973907B2Apr 13, 2021
Recombinant adenoviruses encoding mosaic human immunodeficiency virus (HIV) Env, Gag, and Pol antigens
JANSSEN VACCINES & PREVENTION BV0 citations59
US11723970B2Aug 15, 2023
Poxvirus vectors encoding HIV antigens, and methods of use thereof
JANSSEN VACCINES & PREVENTION BV1 citations58
US11229693B2Jan 25, 2022
Poxvirus vectors encoding HIV antigens, and methods of use thereof
JANSSEN VACCINES & PREVENTION BV1 citations58
US11517618B2Dec 6, 2022
Method of inducing an immune response against human immunodeficiency virus by co-localized administration of vaccine components
JANSSEN VACCINES & PREVENTION BV0 citations52
JANSSEN PHARMACEUTICALS INC
2 patentsUS11498944B2Nov 15, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC10 citations81
US11384122B2Jul 12, 2022
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2 vaccines
JANSSEN PHARMACEUTICALS INC2 citations68